P. Gaillard

Imaged-guided focused ultrasound in combination with various formulations of doxorubicin for the treatment of diffuse intrinsic pontine glioma
202212 citationsauthor #4
Nanomedicines for Brain Drug Delivery
20215 citationsauthor #2
Systemic and intraocular administration of the liposomal formulation of the cyclic GMP analogue CN03: An exploratory safety and tolerability study in non-human primates
20190 citationsauthor #3
Drug delivery to retinal photoreceptors
201954 citationsauthor #4
Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
201943 citationsauthor #2
Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration
201897 citationsauthor #17
Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
20182 citationsauthor #11
In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.
201823 citationsauthor #2
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
201710 citationsauthor #11
The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
201738 citationsauthor #3
Treatment with penicillin G and hydrocortisone reduces ALS-associated symptoms: a case series of three patients
20175 citationsauthor #3
BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery.
20168 citationsauthor #1
The DRUGSFORD project: Preservation of retinal morphology and function in different in vivo models for hereditary retinal degeneration
20160 citationsauthor #8
Patient-reported adverse effects of high-dose intravenous methylprednisolone treatment: a prospective web-based multi-center study in multiple sclerosis patients with a relapse
201644 citationsauthor #16
Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.
201674 citationsauthor #10
Abstract P6-16-04: Phase 1/2a study of glutathione PEGylated liposomal doxorubicin (2B3-101) in breast cancer patients with brain metastases
20153 citationsauthor #10
In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes
20150 citationsauthor #4
Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
2015133 citationsauthor #7
Corrigendum to “A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes” [Exp. Eye Res. 96 (1) (2012) 181–190]
20150 citationsauthor #4
In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes
201548 citationsauthor #4
Recent Advances and Trends in the Brain Delivery of Small Molecule Based Cancer Therapies
20150 citationsauthor #7
Systemic treatment with glutathione PEGylated liposomal methylprednisolone (2B3-201) improves therapeutic efficacy in a model of ocular inflammation.
201423 citationsauthor #5
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
2014247 citationsauthor #1
Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)--a cerebral open flow microperfusion pilot study.
201499 citationsauthor #8
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
201427 citationsauthor #2
Abstract CT216: Phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma
201428 citationsauthor #1
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
201447 citationsauthor #6
Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat.
201418 citationsauthor #4
Blood-to-Brain Drug Delivery Using Nanocarriers
201424 citationsauthor #1
NT-23PHASE 1/2A STUDY OF GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN (2B3-101) IN BREAST CANCER PATIENTS WITH BRAIN METASTASES (BCBM) OR RECURRENT HIGH GRADE GLIOMAS (HGG)
201411 citationsauthor #11
Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats
2014129 citationsauthor #12
CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
20141 citationsauthor #2
Optimized delivery of an anti-amyloid VHH-2H heavy chain antibody fragment to the mouse brain
20130 citationsauthor #5
Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.
201393 citationsauthor #3
CNS-TARGETED METHYLPREDNISOLONE REDUCES PATHOLOGY IN MOUSE MODEL OF ALS
20130 citationsauthor #3
Abstract 4342: 2B3-201, glutathione pegylated liposomal methylprednisolone, prevents chemotherapy-induced neuropathic pain.
20130 citationsauthor #1
Challenges in Measuring Active Concentration in the Brain and its Impact for Nanocarrier Delivery
20130 citationsauthor #4
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
2012169 citationsauthor #1
Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancer
201214 citationsauthor #1
A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
201297 citationsauthor #4
Targeted blood-to-brain drug delivery --10 key development criteria.
201219 citationsauthor #1
Enhanced brain drug delivery: safely crossing the blood-brain barrier.
201246 citationsauthor #1
Company Profile: Case study: to-BBB’s G-Technology®, getting the best from drug-delivery research with industry–academia partnerships
201115 citationsauthor #1
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
201119 citationsauthor #3
First evidence of efficacy in brain following intravenous injections of Brain-Targeted Liposome-Enzyme in the MPS II mouse model
20111 citationsauthor #6
The Blood – Brain Barrier and its Effect on Absorption and Distribution
20101 citationsauthor #2
Crossing barriers from blood-to-brain and academia-to-industry.
201022 citationsauthor #1
Melanin and its precursors III. The influence of adrenochrome on the migration of bone marrow in vitro, compared with that of liver extract
20100 citationsauthor #2
2B-Trans technology: targeted drug delivery across the blood-brain barrier.
200830 citationsauthor #1
Transplantation of Cultivated Parathyroid Gland Tissue in Man
20080 citationsauthor #1
Strategies to Improve Drug Delivery Across the Blood-Brain Barrier
2007104 citationsauthor #2
Drug Delivery to the Brain by Internalizing Receptors at the Blood‐Brain Barrier
20072 citationsauthor #1
Diphtheria toxin receptor-targeted brain drug delivery
200577 citationsauthor #1
Targeted delivery across the blood–brain barrier
2005129 citationsauthor #1
In Vivo Methods to Estimate Drug Transport to the Brain Across the Blood-Brain Barrier
20054 citationsauthor #2
The influence of parathyroid hormone on the aggregation of isolated chondrocytes
200514 citationsauthor #1
Induction of bone formation in explanted bone rudiments by calcitonin and imidazole
20051 citationsauthor #1
Validation of the Transferrin Receptor for Drug Targeting to Brain Capillary Endothelial Cells In Vitro
2004102 citationsauthor #4
Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro.
200385 citationsauthor #1
The role of drug transporters at the blood-brain barrier.
2003241 citationsauthor #3
Renal oncocytoma with a novel chromosomal rearrangement,
20021 citationsauthor #1
The blood-brain barrier and drug transport to the brain
20021 citationsauthor #2
Glucocorticoid and type 1 interferon interactions at the blood–brain barrier: relevance for drug therapies for multiple sclerosis
200135 citationsauthor #1
Modulators of Blood-Brain Barrier (BBB) Permeability: In Vitro and in Vivo Drug Transport to the Brain
20010 citationsauthor #2
P-Glycoprotein Inhibition Leads to Enhanced Disruptive Effects by Anti-Microtubule Cytostatics at the In Vitro Blood-Brain Barrier
200128 citationsauthor #2
Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug.
2000167 citationsauthor #1
Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier
2000127 citationsauthor #1
The transference of results between blood-brain barrier cell culture systems.
199932 citationsauthor #2
Differences in striatal extracellular amino acid concentrations between Wistar and Fischer 344 rats after middle cerebral artery occlusion.
199617 citationsauthor #2
Volume Regulation of the in Vitro Blood-Brain Barrier by Osmoreactive Amino Acids during Stress
19960 citationsauthor #1
Blood-brain barrier permeability and stress; a study excitotoxic stress and vasogenic edema
19962 citationsauthor #1
Abstracts of papers and posters Pharmacological Meeting
19940 citationsauthor #76
Regulatory mechanisms in the development of bone and cartilage: the use of tissue culture techniques in the study of the development of embryonic bone and cartilage: a perspective.
19822 citationsauthor #5
Skeletal tissue in culture. Hormonal regulation of metabolism and development.
197915 citationsauthor #1
The effects of gamma irradiation on embryonic bone and cartilage in vitro.
197816 citationsauthor #2
The effects of 1,25-dihydroxycholecalciferol on embryonic bone in vitro: A biochemical and histological study
197810 citationsauthor #2
Comparative endocrinology : proceedings of the 8th International Symposium on Comparative Endocrinology, held in Amsterdam, The Netherlands, 19-23 June 1978
19780 citationsauthor #1
The effect of verapamil on the action of parathyroid hormone on embryonic bone in vitro.
197750 citationsauthor #2
Effects of bone in vitro of bovine parathyroid hormone and synthetic fragments representing residues 1-34, 2-34 and 3-34.
197646 citationsauthor #4
Effects of PTH and some synthetic fragments on embryonic bonein vitro
19751 citationsauthor #1
Structural and ultrastructural responses of calcifying cartilage to parathyroid hormone “in vitro”
19751 citationsauthor #2
Confirmation of hexadecapole deformation in 20Ne from scattering of 68 MeV 3He particles
19741 citationsauthor #4
$sup 52$Mn level investigation from the ($alpha$,d) reaction with $sup 50$Cr
19740 citationsauthor #1
Réaction (τ, p) à 35 MeV sur 42Ca etT 50Cr
19738 citationsauthor #2
Spectroscopy of $sup 52$Mn from the $sup 54$Fe(d,$alpha$) reaction at 15 MeV
19730 citationsauthor #1
Medium energy cluster knock-out reactions on 6Li and their interpretation in terms of distorted waves
197328 citationsauthor #4
Spectroscopy of 52 Mn from the 54 Fe(d, α) Reaction at 15 MeV
19732 citationsauthor #1
(tau,p) reaction on $sup 42$Ca and $sup 50$Cr at 35 MeV
19730 citationsauthor #2
A comparative study on the effects of imidazole and 1,2,4-triazole on explanted mouse and rat bone rudiments.
19720 citationsauthor #1
REACTION (d,$alpha$) ON $sup 54$Fe AT 28 MeV.
19710 citationsauthor #3
COMPARISON OF ($alpha$,2$alpha$) AND ($alpha$,$alpha$t) REACTIONS WITH $sup 19$F AT 60.2 MeV.
19710 citationsauthor #2
Study of the Mechanism of the (α,2α) Reaction onLi6
197023 citationsauthor #1
STUDY OF THE MECHANISM OF THE ($alpha$,2$alpha$) REACTION ON $sup 6$Li.
19700 citationsauthor #1
COMPARISON OF THE REACTIONS ($alpha$,$sup 3$He) AND ($alpha$) ON SOME NUCLEI N = Z.
19690 citationsauthor #1
The effect of parathyroid extract on the aggregation and the secretion of isolated chondrocytes.
19695 citationsauthor #1
STUDY OF ($alpha$,2$alpha$) REACTIONS ON $sup 6$Li, $sup 7$Li, AND $sup 9$Be AT 55 MeV.
19690 citationsauthor #3
The effect of parathyroid hormone on desmal and long bone rudiments "in vitro".
19680 citationsauthor #1
THE REACTION $sup 14$N(d,$alpha$)$sup 12$C AT 28.5 MeV.
19670 citationsauthor #6
Bone culture studies with thyrocalcitonin.
19679 citationsauthor #1
Thyrocalcitonin and bone in vitro.
19670 citationsauthor #1

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT